{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:19:55Z","timestamp":1791836395221,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejpb.2020.12.021","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:17:52Z","timestamp":1609586272000},"page":"77-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Best practices for selection of excipients for paediatrics \u2013 Workshop reflection"],"prefix":"10.1016","volume":"160","author":[{"given":"Smita","family":"Salunke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clapham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.12.021_b0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijpharm.2017.08.088","article-title":"Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop","volume":"536","author":"Ternik","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.12.021_b0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1211\/jpp.59.8.0001","article-title":"Developing paediatric medicines: identifying the needs and recognizing the challenges","volume":"59","author":"Ernest","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.12.021_b0015","unstructured":"A. Al-khattawi, A.R. Mohammed, Excipients in medicines for children: scientific and regulatory paradigms, Eur. Pharmaceut. Rev. 2014, https:\/\/www.europeanpharmaceuticalreview.com\/article\/24946\/excipients-medicines-children-scientific-regulatory-paradigms\/ [accessed 16 November 2020]."},{"key":"10.1016\/j.ejpb.2020.12.021_b0020","first-page":"251","article-title":"Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered","volume":"32","author":"Valeur","year":"2018","journal-title":"Pharmaceut Med."},{"key":"10.1016\/j.ejpb.2020.12.021_b0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/jphp.12610","article-title":"Evidence of acceptability of oral paediatric medicines: a review","volume":"69","author":"Mistry","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.12.021_b0030","unstructured":"EMA. European Medicines Agency Committee for Medicinal Products for Human Use and Paediatric Committee (2013) Guideline on the pharmaceutical development of medicines for paediatric use. EMA\/CHMP\/QWP\/805880\/2012 Rev. 2. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf [accessed 16\/11\/20]. 2013."},{"key":"10.1016\/j.ejpb.2020.12.021_b0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2013.11.003","article-title":"Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas","volume":"73","author":"Turner","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.12.021_b0040","unstructured":"IPEC. The International Pharmaceutical Excipients Council, Qualification of Excipients for Use in Pharmaceuticals. https:\/\/ipecamericas.org\/sites\/default\/files\/ExcipientQualificationGuide.pdf [Accessed 24\/11\/2020]. 2008."},{"key":"10.1016\/j.ejpb.2020.12.021_b0045","unstructured":"Clapham D, Hughes K, Anjali A, Nunn A, Salunke S. EuPFI 10th Conference \u2013 workshop presentation. Best practices in the selection of excipients for paediatrics. http:\/\/www.eupfi.org\/past-conferences\/10th-eupfi-conference\/. 2018."},{"key":"10.1016\/j.ejpb.2020.12.021_b0050","unstructured":"Slocum N. Participatory Methods Toolkit: a Practitioner's Manual: King Baudouin Foundation. https:\/\/cris.unu.edu\/sites\/cris.unu.edu\/files\/Toolkit.pdf [Accessed 24\/11\/2020]; 2003."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:41:05Z","timestamp":1760546465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120303799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":10,"alternative-id":["S0939641120303799"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.12.021","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best practices for selection of excipients for paediatrics \u2013 Workshop reflection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}